« Previous | Contents |
Listen
Good Practice Statement for the Preparation of Injections in Near-Patient Areas, including Clinical and Home Environments
APPENDIX 8 REFERENCES
1.
Our National Health: A Plan for Action and Plan for Change. SEHD 2000.
2.
Building a safer NHS for patients: Implementing An Organisation with a Memory. DoH April 2001.
3. Learning from Bristol: The Report of the Public Inquiry into children's heart surgery at the Bristol Royal Infirmary 1984-85. Command Paper 5207 (2001) Recommendation 121.
4. MEL(1998)75 MEL(2000)29, HDL(2001)74.
5. A Quality and Standards Board for Health in Scotland: Consultation Paper
http://www/show.scot.nhs.uk/sehd/publications/qsbsconsult.pdf
6.
An Organisation with a Memory. DoH 2000.
7.
A Spoonful of Sugar. Audit Commission 2001, paragraph 46.
8. Association of Scottish Trust Chief Pharmacists. Report of the centralised intravenous additives service (CIVAS) task team. April 1999.
9. Cousins D.H, Upton D.R. How to prevent IV drug errors.
Pharm Pract 1997;
7:310-312.
10. Cousins D.H, Upton D.R. Stop these parenteral blunders.
Hosp Pharm Pract 1994;4:387-388.
11. Baird R, Doery H. In-use contamination of intravenous fluids.
J Clin Hosp Pharm 1981; 6: 183-8.
12. Denyer S.P, Blackburn J.E, Worrall A.K, Young S.M, Ellis S.J. In-use microbiological contamination of IV infusion fluids.
Pharm J 1981; 227: 419-23.
13. Ernerot L, Thorén S, Sandell E. Studies on microbial contamination of infusion fluids arising from drug additions and administration.
Acta Pharm Suecica 1973; 10: 141-6.
14. Hanson A.L, Nighswander R.M, Verhulst J.H. A study to determine the incidence of bacterial and fungal contamination in IV solutions and their administration sets with patient safety the primary concern.
Hosp Formulary Management 1973; 8: 17-21.
15. Hanson A.L, Shelley R.M. Monitoring contamination levels of in-use intravenous solutions using "total sample" techniques.
Am J Hosp Pharm 1974; 31: 733-5.
16. Letcher K.I, Thrupp L.D, Schapiro D.J, Boesma J.E. In-use contamination of intravenous solutions in flexible plastic containers.
Am J Hosp Pharm 1972; 29: 673-7.
17. Maki D.G, Anderson R.L, Shulman J.A. In-use contamination of intravenous infusion fluids.
Appl Microbiol 1974; 28(5): 778.
18. Ravin R, Bahr J, Luscomb F, Gooch J, Mutter S, Spittell S.D. Program for bacterial surveillance of intravenous admixtures.
Am J Hosp Pharm 1974; 31: 340-7.
19. Stjernstrom G, Gunnarsson R, Wikner H. Studies on microbiological contamination of in-use IV fluids.
Acta Pharm Suecica 1978; 15: 169-74.
20. Woodside W, Woodside M, D'Arcy E, Patel H. Intravenous fluids as vehicles of infection.
Pharm J 1975; 215: 606.
21. Langford S. Mortality and morbidity from the in-use microbial contamination of intravenous products.
Hosp Pharm 1999; 6: 104-109.
22.
Quality Assurance of Aseptic Preparation Services (3rd Edition), Pharmaceutical Press, 2001.
23. McDonald A, Millar B, Kendle K, McElduff N, Dodd T. Intravenous medicines: does ward based preparation compromise quality?
CRAG Occasional Paper No. 31 1992.
24. Munro M. Risk assessment of the preparation of parenteral medicines in clinical areas in Perth Royal Infirmary. HNC Project in Pharmaceutical Sciences 2001 (Telford College, Edinburgh).
25. McDonald A. Evaluation of risks associated with the preparation of intravenous injections and infusions on the wards of hospitals in Tayside. MPhil Thesis 1993 (The Robert Gordon University, Aberdeen).
26. Breckenridge A. HC(76)9. The report of the working party on the addition of drugs to intravenous fluids. Department of Health and Social Security.
27. Aseptic Dispensing for NHS Patients, Department of Health, 1995. (The Farwell Report).
28. Scottish Executive Health Department, National Pharmaceutical Forum. National guidance on the safe administration of intrathecal injections. Draft 4, December 2001.
29. Aseptic Dispensing Process Guidelines, ASSIG, 1996.
30. Guidelines on Environmental Monitoring for Aseptic Dispensing Facilities,
QASIG, Second Edition, 1998.
31. Guidelines on Test Methods for Environmental Monitoring for Aseptic Dispensing Facilities,
QASIG, First Edition, 1999.
32. Guidelines for Process Simulation Tests for Aseptic Dispensing Processes,
ASSIG/QASIG, First Edition, 1999.
33. Guidelines for Determining Clean Up Times for Clean Rooms/Clean Air Devices Following Shut Down of Air Handling Units/Devices,
QASIG, First Edition, 2000.
34. Templates for Service Specifications and Agreement,
ASSIG/QASIG, 2000.
35. Audit Schedule for Microbiology Services to Aseptic Dispensaries,
QASIG, First Edition, 2000.
36. Scottish Executive Health Department/Association of Scottish Trust Chief Pharmacists. Guidelines for the safe use of cytotoxic chemotherapy in the clinical environment. Issued under cover of NHS HDL (2001) 13, 22 February 2001.
37. Medicines Act 1968. London: HMSO 1968.
« Previous | Contents |